Seegakula Pharmaceuticals Private Limited
About Seegakula Pharmaceuticals Private Limited
Data last updated:
Seegakula Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2007PTC042292. Its GSTIN is 29AAMCS7651L1ZI (Karnataka).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹94.72 Lakh. It is led by directors including Seegakula Sathyanarayana Setty and Manoj Nagaraj.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No. 324 1st Stage Sompura Industrial Area Sompura Nelamangala Taluk, Bengaluru, Karnataka, India – 562132.
As per the financials filed for FY 2022, the company reported a revenue of ₹3.07 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹85.32 Lakh (net margin -27.8%) and EBITDA of ₹14.13 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years and 175% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.91 Cr and satisfied charges of ₹6.91 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 324 1st Stage Sompura Industrial Area Sompura Nelamangala Taluk, Bengaluru, Karnataka, India – 562132
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Seegakula Pharmaceuticals Private Limited
The main business activity of Seegakula Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Seegakula Pharmaceuticals Private Limited FY 2023 filings available
Seegakula Pharmaceuticals Private Limited reported revenue of ₹3.07 Cr (up 11% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Seegakula Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 175% over five years, including 11% growth in the latest year. EBITDA rose 165% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Seegakula Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹85.32 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Seegakula Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -27.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Seegakula Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shubh Pharma Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | -43.0% | •••• | Thane, Maharashtra, India |
| Ganga Pharmaceuticals Ltd Listed | ₹3.07 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Palghar, Maharashtra, India |
| Venova Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Sitnez Biocare Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| JVJ Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Indore, Madhya Pradesh, India |
| Seegakula Pharmaceuticals Private Limited this company | ₹3.07 Cr (FY 2022) | •••• | •••• | 11.0% | •••• | Bengaluru, Karnataka, India |
| Medrexcare Pharma Private Limited | ₹3.06 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Ralington Pharma LLP | ₹3.06 Cr (FY 2021) | •••• | •••• | 364.0% | •••• | Sanand, Gujarat, India |
| Alisier Drugs Private Limited | ₹3.06 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Ambala Cantt, Haryana, India |
| Verdeus Naturals Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | •••• | Mysore, Karnataka, India | |
| Teblik Drugs Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Seegakula Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals Private Limited is audited by SHASHANK AND NIJAGAL for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHASHANK AND NIJAGAL | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seegakula Sathyanarayana Setty | Director | 29 Mar 2007 | 19 Years 6 Months | Current |
| Manoj Nagaraj Also directs: Naga Metals Private Limited | Director | 29 Jan 2018 | 8 Years 8 Months | Current |
| Hariharan Sakthivel | Director | 29 Jan 2018 | 8 Years 8 Months | Current |
| Sujatha Sathyanarayana | Director | 29 Mar 2007 | 19 Years 6 Months | Current |
Ownership and Shareholding of Seegakula Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Seegakula Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2016 | State Bank of India | ₹6.91 Cr | Satisfied |
Total charge records: 1 View all charges
Legal Cases of Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals Private Limited has a workforce of 2 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals Private Limited has 11 board changes on record since 2007: 5 appointments and 6 cessations. The latest: Ahmad Shabir was appointed as Additional Director on 30 Mar 2025.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Seegakula Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Seegakula Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Seegakula Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAMCS7651L1ZI | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Seegakula Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seegakula Pharmaceuticals Private Limited
Seegakula Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 2007 (19+ years old) and is registered under CIN U24232KA2007PTC042292.
Seegakula Pharmaceuticals reported revenue of ₹3.07 Cr for FY 2022 (up 11% YoY).
Seegakula Pharmaceuticals has 4 current directors:
- Seegakula Sathyanarayana Setty - Director
- Manoj Nagaraj - Director
- Hariharan Sakthivel - Director
- Sujatha Sathyanarayana - Director
Seegakula Pharmaceuticals reported a net loss of ₹85.32 Lakh (net margin -27.8%) and EBITDA of ₹14.13 Lakh (EBITDA margin 4.6%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Seegakula Pharmaceuticals is 64% over three years and 175% over five years. In the latest year (FY 2022) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Seegakula Pharmaceuticals is 29AAMCS7651L1ZI, registered in Karnataka.
The CIN (Corporate Identification Number) of Seegakula Pharmaceuticals is U24232KA2007PTC042292. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seegakula Pharmaceuticals has 2 court cases on record: 2 filed against it.
Seegakula Pharmaceuticals was incorporated on 29 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Seegakula Pharmaceuticals by revenue are Shubh Pharma Private Limited, Ganga Pharmaceuticals Ltd, Venova Pharmaceuticals Private Limited, Sitnez Biocare Private Limited, JVJ Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Ahmad Shabir was appointed as Additional Director on 30 Mar 2025. Hariharan Sakthivel ceased to be Additional Director on 29 Sep 2018. Manoj Nagaraj ceased to be Additional Director on 29 Sep 2018. Seegakula Pharmaceuticals has 11 board changes on record in total.